Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Richard Brundage, Pharm.D., Ph.D., Mark W. Kline, M.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D. Pharmacokinetics of saquinavir (SQV) with nelfinavir (NFV) or ritionavir (RTV) in HIV-infected.
K Brooks, M Pinilla, J Wang, D Shapiro, E Capparelli, E Smith, N Chakhtoura, A Stek, M Mirochnick, B Best for the IMPAACT 1026s Protocol team. Pharmacokinetics of Tenofovir Alafenamide 25 mg with PK Boosters During Pregnancy and Postpartum. Presented at: 20th International Workshop on Clinical Pharmacology of HIV Hepatitis & Other Antiviral Drugs Conference.

Conference

20th International Workshop on Clinical Pharmacology of HIV< Hepatitis & Other Antiviral Drugs Conference

Study

P1026S
Tim R. Cressey, Rohan Hazra, Andrew Wiznia, Marc Foca, Patrick Jean-Philipe, Bobbie Graham, Paula Britto, Vincent J. Carey, Edward P. Acosta, Ram Yogev, the IMPAACT P1058A team. Pharmacokinetics of Unboosted Atazanavir in Adolescents and Young Adults. Presented at: CROI 2015.

Conference

CROI 2015

Study

P1058A
B Best, K Yee, M Farhad, C Alvero, P Morgan, K McCarthy, H Teppler, S Kumar, N Tobin, E McFarland, E Townley, A Melvin for the I2014 Team. Pharmacokinetics, Safety and Tolerability of Doravirine in HIV-1-infected Adolescents. Presented at: International Pediatric HIV Workshop; 2019 Jul 20.

Conference

International Pediatric HIV Workshop

Study

IMPAACT 2014
Pharmacokinetics, Safety, and Efficacy of Dolutegravir (DTG; S/GSK1349572) in HIV-1 Infected Adolescents: Preliminary analysis from IMPAACT 1093. Presented at: XIX International AIDS Conference.

Conference

XIX International AIDS Conference

Study

P1093
Courtney V. Fletcher, Pharm.D., Terence Fenton, Ed.D., Christine Powell, M.A., Peter Anderson, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Stephen A. Spector, M.D., Stuart E. Starr, M.D. Pharmacologic of efavirenz (EFV) and Nelfinavir (NFV) associated with virologic response in HIV-infected children.
Mark W. Kline, M.D., Suzette Blanchard, M.S., Ph.D., Jerry L. Shenep, M.D., Ross E. McKinney, Jr., M.D., Russell B. Van Dyke, M.D., Mary Culnane, C.R.N.P., M.S., Seth Hetherington, M.D. Phase I Study of 1592U89 in HIV-Infected Infants and Children.
Yvonne J. Bryson, M.D., Alice M. Stek, M.D., Mark Mirochnick, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., Jerry Snidow, Pharm.D., Merrill J. Gersten, M.D. Phase I Study Of Safety, Pharmacokinetics, and Antiviral Activity Of Combination Nelfinavir (NFV), ZDV and 3TC In HIV-Infected Pregnant Women and Their Infants.
Yvonne J. Bryson, M.D., Alice M. Stek, M.D., Mark Mirochnick, M.D., Sharon Huang, M.S., Michael Hughes, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., Jerry Snidow, Pharm.D., Merrill J. Gersten, M.D. Phase I Study Of Safety, Pharmacokinetics, and Antiviral Activity Of Combination Nelfinavir (NFV), ZDV and 3TC In HIV-Infected Pregnant Women and Their Infants.
Daniel Johnson, M.D., Minhee Kang, M.S., Ph.D., Terence Fenton, Ed.D., James McNamara, M.D., Elizabeth Hawkins, Stuart E. Starr, M.D., Pamela Bouquin, B.A., Rafaelle El-Habib, Ph.D., Jean Louis Excler, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, John S. Lambert, M.D. Phase I Study of the Safety and Immunogenicity of an ALVAC Vaccine in Children Born to HIV Infected Mothers: Preliminary Results.